IMGN - ImmunoGen GAAP EPS of -$0.16 beats by $0.09 revenue of $49.87M April, 28 2023 06:36 AM ImmunoGen Inc. 2023-04-28 06:36:57 ET ImmunoGen press release ( NASDAQ: IMGN ): Q1 GAAP EPS of -$0.16 beats by $0.09 . Revenue of $49.87M (+31.0% Y/Y). For further details see: ImmunoGen GAAP EPS of -$0.16 beats by $0.09, revenue of $49.87M